LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 114

Search options

  1. Article ; Online: Once weekly semaglutide and cardiovascular outcomes in patients with type 2 diabetes and heart failure with reduced left ventricular ejection fraction.

    Pérez-Velasco, Miguel A / Trenas, Alicia / Bernal-López, M Rosa / García de Lucas, María D / Gómez-Huelgas, Ricardo / Pérez-Belmonte, Luis M

    Revista espanola de cardiologia (English ed.)

    2024  

    Language Spanish
    Publishing date 2024-01-16
    Publishing country Spain
    Document type Case Reports
    ZDB-ID 2592481-3
    ISSN 1885-5857 ; 1885-5857
    ISSN (online) 1885-5857
    ISSN 1885-5857
    DOI 10.1016/j.rec.2023.12.008
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Relationship between quadriceps femoris echotexture biomarkers and muscle strength and physical function in older adults with heart failure with preserved ejection fraction.

    Fuentes-Abolafio, Iván José / Ricci, Michele / Bernal-López, María Rosa / Gómez-Huelgas, Ricardo / Cuesta-Vargas, Antonio Ignacio / Pérez-Belmonte, Luis Miguel

    Experimental gerontology

    2024  Volume 190, Page(s) 112412

    Abstract: Background: Muscle wasting is pronounced in patients with heart failure with preserved ejection fraction (HFpEF). The quadriceps femoris echotexture biomarkers assessed by ultrasound (US) have not been studied in these patients.: Objective: To ... ...

    Abstract Background: Muscle wasting is pronounced in patients with heart failure with preserved ejection fraction (HFpEF). The quadriceps femoris echotexture biomarkers assessed by ultrasound (US) have not been studied in these patients.
    Objective: To describe echotexture biomarkers assessed by the US and to assess their relationship with sex, age, body mass index (BMI), self-reported outcomes, muscle strength and physical function in older adults with HFpEF.
    Methods: A cross-sectional study was conducted. Patients 70 years and older with HFpEF were included. The sex, age, BMI, and self-reported outcomes were collected. The US assessed muscle and subcutaneous fat tissue contrast, correlation, energy, homogeneity, and entropy at rest and maximal voluntary isometrical contraction (MVIC). The six-minute walk test (6MWT), the short physical performance battery (SPPB), the timed up and go test (TUG), the usual pace gait speed test (UGS), and the fast pace gait speed test (FGS) were used to assess physical function. The five-repetitions sit-to-stand test (5-STS) was performed to assess muscle strength. Bivariant Pearson correlations and subsequent multivariate linear regression analyses were conducted.
    Results: Seventy-two older adults with HFpEF [81.06 years, 29.13 BMI, and 55.60% females] were recruited. In women, relaxed and MVIC muscle energy and entropy explained 35.40% of the TUG variance; relaxed muscle entropy and MVIC muscle energy shared 24.00% of the UGS variance; relaxed and MVIC muscle entropy, MVIC muscle contrast and MVIC muscle energy explained 32.60% of the FGS variance, adjusted all the models by age and BMI.
    Conclusions: Echotexture biomarkers are related to women's muscle strength and physical function, especially muscle energy, contrast, and entropy. Echotexture biomarkers assessed by the US could facilitate the management of older adults with HFpEF, monitor its progression and assess the effectiveness of treatments on the musculoskeletal structure.
    Trial registration: NCT03909919. April 10, 2019. Retrospectively registered.
    Language English
    Publishing date 2024-04-05
    Publishing country England
    Document type Journal Article
    ZDB-ID 390992-x
    ISSN 1873-6815 ; 0531-5565
    ISSN (online) 1873-6815
    ISSN 0531-5565
    DOI 10.1016/j.exger.2024.112412
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Remission of type 2 diabetes: A critical appraisal.

    Ricci, Michele / Mancebo-Sevilla, Juan José / Cobos Palacios, Lidia / Sanz-Cánovas, Jaime / López-Sampalo, Almudena / Hernández-Negrin, Halbert / Pérez-Velasco, Miguel Angel / Pérez-Belmonte, Luis M / Bernal-López, Maria Rosa / Gómez-Huelgas, Ricardo

    Frontiers in endocrinology

    2023  Volume 14, Page(s) 1125961

    MeSH term(s) Humans ; Diabetes Mellitus, Type 2/therapy ; Hypoglycemic Agents ; Insulin
    Chemical Substances Hypoglycemic Agents ; Insulin
    Language English
    Publishing date 2023-04-03
    Publishing country Switzerland
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2592084-4
    ISSN 1664-2392
    ISSN 1664-2392
    DOI 10.3389/fendo.2023.1125961
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Reply to: Comment on: Clinical benefits of empagliflozin in very old patients with type 2 diabetes hospitalized for acute heart failure.

    Pérez-Belmonte, Luis M / Miramontes-González, José P / Osuna-Sánchez, Julio / Lara, José P / Gómez-Huelgas, Ricardo

    Journal of the American Geriatrics Society

    2022  Volume 70, Issue 5, Page(s) 1585–1589

    MeSH term(s) Benzhydryl Compounds/therapeutic use ; Diabetes Mellitus, Type 2/complications ; Diabetes Mellitus, Type 2/drug therapy ; Glucosides/therapeutic use ; Heart Failure/drug therapy ; Humans
    Chemical Substances Benzhydryl Compounds ; Glucosides ; empagliflozin (HDC1R2M35U)
    Language English
    Publishing date 2022-02-17
    Publishing country United States
    Document type Letter ; Comment
    ZDB-ID 80363-7
    ISSN 1532-5415 ; 0002-8614
    ISSN (online) 1532-5415
    ISSN 0002-8614
    DOI 10.1111/jgs.17703
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Relationship between quadriceps femoris muscle architecture and muscle strength and physical function in older adults with heart failure with preserved ejection fraction.

    Fuentes-Abolafio, Iván J / Bernal-López, M Rosa / Gómez-Huelgas, Ricardo / Ricci, Michele / Cuesta-Vargas, Antonio I / Pérez-Belmonte, Luis M

    Scientific reports

    2022  Volume 12, Issue 1, Page(s) 21660

    Abstract: Heart failure (HF)-related factors potentially lead to sarcopenia. Ultrasound (US) assessment has all the advantages of being used in clinical practice to assess muscle architecture. This study aimed to assess the relationship between the quadriceps ... ...

    Abstract Heart failure (HF)-related factors potentially lead to sarcopenia. Ultrasound (US) assessment has all the advantages of being used in clinical practice to assess muscle architecture. This study aimed to assess the relationship between the quadriceps femoris (QF) muscle architecture with the gender, age, body mass index (BMI), muscle strength and physical function in older adults with HF with preserved ejection fraction (HFpEF) as well as to assess the difference in these relationships between the two genders. Patients 70 years and older with HFpEF were included. The gender, age and BMI were collected. The QF muscle thickness, the QF muscle echo-intensity, the subcutaneous fat tissue thickness (FT) and the subcutaneous fat tissue echo-intensity were assessed by the US. The six-minute walk test, the short physical performance battery (SPPB), the timed up and go test (TUG), and the gait speed test (UGS) were used to assess physical function. The five-repetitions sit-to-stand test (5-STS) was performed to assess muscle strength. Bivariant Pearson correlations and subsequent multivariate linear regression analysis were conducted. Seventy older adults with HFpEF [81.00 (5.97) years] were recruited. The FT showed a correlation between poor and moderate muscle strength and physical function in women with HFpEF. The FT explained 24.5% of the 5-STS variance, 32.4% of the SPPB variance, 31.5% of the TUG variance, 28.6% of the UGS variance, and 21.4% of the FGS variance in women. The US assessment could allow clinicians to assess muscle architecture biomarkers related to muscle strength and physical function in older adults with HFpEF.Trial registration NCT03909919. April 10, 2019. Retrospectively registered.
    Language English
    Publishing date 2022-12-15
    Publishing country England
    Document type Journal Article
    ZDB-ID 2615211-3
    ISSN 2045-2322 ; 2045-2322
    ISSN (online) 2045-2322
    ISSN 2045-2322
    DOI 10.1038/s41598-022-26064-7
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Adverse outcomes in patients with heart failure admitted for COVID‑19 in association with the use of renin-angiotensin‑aldosterone system inhibitors.

    Pérez-Belmonte, Luis M / Sanz-Cánovas, Jaime / Salinas, Alejandro / Garcia-Klepzig, Jose Luis / Méndez-Bailón, Manuel / Gómez-Huelgas, Ricardo

    Polish archives of internal medicine

    2021  Volume 132, Issue 1

    MeSH term(s) Angiotensin Receptor Antagonists/adverse effects ; COVID-19 ; Heart Failure/drug therapy ; Humans ; Renin-Angiotensin System ; SARS-CoV-2
    Chemical Substances Angiotensin Receptor Antagonists
    Language English
    Publishing date 2021-10-22
    Publishing country Poland
    Document type Journal Article
    ZDB-ID 123500-x
    ISSN 1897-9483 ; 0032-3772
    ISSN (online) 1897-9483
    ISSN 0032-3772
    DOI 10.20452/pamw.16126
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: The Role of Heparin in Postural Orthostatic Tachycardia Syndrome and Other Post-Acute Sequelae of COVID-19.

    Gómez-Moyano, Elisabeth / Pavón-Morón, Javier / Rodríguez-Capitán, Jorge / Bardán-Rebollar, Daniel / Ramos-Carrera, Teresa / Villalobos-Sánchez, Aurora / Pérez de Pedro, Iván / Ruiz-García, Francisco J / Mora-Robles, Javier / López-Sampalo, Almudena / Pérez-Velasco, Miguel A / Bernal-López, Maria-Rosa / Gómez-Huelgas, Ricardo / Jiménez-Navarro, Manuel / Romero-Cuevas, Miguel / Costa, Francesco / Trenas, Alicia / Pérez-Belmonte, Luis M

    Journal of clinical medicine

    2024  Volume 13, Issue 8

    Abstract: The therapeutic management and short-term consequences of the coronavirus disease 2019 (COVID-19) are well known. However, COVID-19 post-acute sequelae are less known and represent a public health problem worldwide. Patients with COVID-19 who present ... ...

    Abstract The therapeutic management and short-term consequences of the coronavirus disease 2019 (COVID-19) are well known. However, COVID-19 post-acute sequelae are less known and represent a public health problem worldwide. Patients with COVID-19 who present post-acute sequelae may display immune dysregulation, a procoagulant state, and persistent microvascular endotheliopathy that could trigger microvascular thrombosis. These elements have also been implicated in the physiopathology of postural orthostatic tachycardia syndrome, a frequent sequela in post-COVID-19 patients. These mechanisms, directly associated with post-acute sequelae, might determine the thrombotic consequences of COVID-19 and the need for early anticoagulation therapy. In this context, heparin has several potential benefits, including immunomodulatory, anticoagulant, antiviral, pro-endothelial, and vascular effects, that could be helpful in the treatment of COVID-19 post-acute sequelae. In this article, we review the evidence surrounding the post-acute sequelae of COVID-19 and the potential benefits of the use of heparin, with a special focus on the treatment of postural orthostatic tachycardia syndrome.
    Language English
    Publishing date 2024-04-20
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2662592-1
    ISSN 2077-0383
    ISSN 2077-0383
    DOI 10.3390/jcm13082405
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Biomarkers and the quadriceps femoris muscle architecture assessed by ultrasound in older adults with heart failure with preserved ejection fraction: a cross-sectional study.

    Fuentes-Abolafio, Iván José / Ricci, Michele / Bernal-López, María Rosa / Gómez-Huelgas, Ricardo / Cuesta-Vargas, Antonio Ignacio / Pérez-Belmonte, Luis Miguel

    Aging clinical and experimental research

    2022  Volume 34, Issue 10, Page(s) 2493–2504

    Abstract: Background: Sarcopenia is an important comorbidity in patients with heart failure with preserved ejection fraction (HFpEF). The ultrasound (US) assessment has all the advantages of being used in primary care to assess muscle quantity and quality. Some ... ...

    Abstract Background: Sarcopenia is an important comorbidity in patients with heart failure with preserved ejection fraction (HFpEF). The ultrasound (US) assessment has all the advantages of being used in primary care to assess muscle quantity and quality. Some biomarkers could be indicative of muscle mass loss.
    Aims: To describe the quantitative and qualitative characteristics of the quadriceps femoris assessed by US in older adults with HFpEF and to assess the relationship of the blood and urinary biomarkers, the polypharmacy and comorbidities with US outcomes in older adults with HFpEF.
    Methods: A cross-sectional study was conducted. 76 older adults with HFpEF were included. The quadriceps femoris muscle thickness (MT, cm), the subcutaneous fat tissue thickness (FT, cm), the muscle echo intensity (MEI) and the subcutaneous fat tissue echo intensity (FEI) were assessed by US in a non-contraction (non-con) and contraction (con) situations. Polypharmacy, comorbidities, blood and urine biomarkers were also collected.
    Results: The carbohydrate antigen 125 (CA-125), the folic acid and the urine creatinine shared the 86.6% variance in the non-con MT, adjusted by age, sex and body mass index (BMI). The folic acid shared the 38.5% of the variance in the con MT, adjusted by age, sex and BMI. The glycosylated haemoglobin explained the 39.6% variance in the non-con MEI, adjusted by age, sex and BMI. The chlorine (Cl
    Conclusions: Blood and urinary biomarkers obtained in routine analyses could help clinicians detect US outcome changes in older adults with HFpEF and identify a worsening of sarcopenia.
    Trial registration: NCT03909919. April 10, 2019. Retrospectively registered.
    MeSH term(s) Aged ; Humans ; Biomarkers ; Cross-Sectional Studies ; Folic Acid ; Heart Failure/diagnostic imaging ; Muscle Strength/physiology ; Quadriceps Muscle/diagnostic imaging ; Sarcopenia ; Stroke Volume ; Male ; Female
    Chemical Substances Biomarkers ; Folic Acid (935E97BOY8)
    Language English
    Publishing date 2022-08-08
    Publishing country Germany
    Document type Clinical Study ; Journal Article
    ZDB-ID 2104785-6
    ISSN 1720-8319 ; 1594-0667
    ISSN (online) 1720-8319
    ISSN 1594-0667
    DOI 10.1007/s40520-022-02189-7
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Corticosteroid therapy in patients with heart failure hospitalized for COVID-19: a multicenter retrospective study.

    Pérez-Belmonte, Luis M / Sanz-Cánovas, Jaime / Salinas, Alejandro / Fornie, Iñigo Sagastagoitia / Méndez-Bailón, Manuel / Gómez-Huelgas, Ricardo

    Internal and emergency medicine

    2021  Volume 16, Issue 8, Page(s) 2301–2305

    MeSH term(s) Adrenal Cortex Hormones/adverse effects ; Adrenal Cortex Hormones/therapeutic use ; Aged ; COVID-19/complications ; COVID-19/drug therapy ; COVID-19/mortality ; Critical Care/methods ; Female ; Heart Failure/complications ; Heart Failure/drug therapy ; Heart Failure/mortality ; Hospital Mortality ; Humans ; Hydroxychloroquine/therapeutic use ; Length of Stay/statistics & numerical data ; Male ; Middle Aged ; Retrospective Studies ; Severity of Illness Index
    Chemical Substances Adrenal Cortex Hormones ; Hydroxychloroquine (4QWG6N8QKH)
    Language English
    Publishing date 2021-10-12
    Publishing country Italy
    Document type Letter ; Multicenter Study
    ZDB-ID 2454173-4
    ISSN 1970-9366 ; 1828-0447
    ISSN (online) 1970-9366
    ISSN 1828-0447
    DOI 10.1007/s11739-021-02843-4
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Simplified glycaemic management for patients with type 2 diabetes admitted for acute decompensated heart failure using linagliptin.

    Pérez-Belmonte, Luis M / Osuna-Sánchez, Julio / Rico-Robles, Juan Ignacio / Ricci, Michele / Lara, José P / Gómez-Huelgas, Ricardo

    Medicina clinica

    2021  Volume 158, Issue 4, Page(s) 173–177

    Abstract: Introduction and objectives: Hyperglycaemia in hospitalized patients with type 2 diabetes is preferably managed with insulin. We aimed to analyse the glycaemic efficacy, treatment simplicity, and safety of our hospital's antihyperglycemic regimens ( ... ...

    Abstract Introduction and objectives: Hyperglycaemia in hospitalized patients with type 2 diabetes is preferably managed with insulin. We aimed to analyse the glycaemic efficacy, treatment simplicity, and safety of our hospital's antihyperglycemic regimens (linagliptin-basal insulin versus basal-bolus insulin) in patients with type 2 diabetes admitted for heart failure decompensation.
    Patients and methods: In this real-world study, we included patients with mild-to-moderate hyperglycaemia managed with our antihyperglycemic regimens between 2016 and 2018. To match patients who started one of the regimens, a propensity matching analysis was used.
    Results: After propensity matching, 146 patients were included in each group. There were no differences in mean blood glucose levels (163.6±21.2 vs 159.6±19.2mg/dl, p=.210). Patients on the linagliptin-basal insulin regimen had a lower total number of hypoglycaemic episodes (36 vs 64, p<.001), lower total insulin dose (24.1±5.3 vs 32.0±5.6 units, p<.001), and lower number of daily injections (2.4±.8 vs 4.0±.0, p<.001) than those on the basal-bolus regimen.
    Conclusions: Linagliptin-basal insulin was a safe, simple, and efficacious regimen and could be considered standard of care for these vulnerable, high complex patients to simplify in-hospital management.
    MeSH term(s) Blood Glucose ; Diabetes Mellitus, Type 2/complications ; Diabetes Mellitus, Type 2/drug therapy ; Glycated Hemoglobin A/analysis ; Heart Failure/drug therapy ; Humans ; Hypoglycemia ; Hypoglycemic Agents/therapeutic use ; Insulin ; Linagliptin/therapeutic use ; Treatment Outcome
    Chemical Substances Blood Glucose ; Glycated Hemoglobin A ; Hypoglycemic Agents ; Insulin ; Linagliptin (3X29ZEJ4R2)
    Language Spanish
    Publishing date 2021-04-10
    Publishing country Spain
    Document type Case Reports
    ZDB-ID 411607-0
    ISSN 1578-8989 ; 0025-7753
    ISSN (online) 1578-8989
    ISSN 0025-7753
    DOI 10.1016/j.medcli.2021.02.009
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top